Skip to content

Clinical trials

Primary Myelofibrosis trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: Bulgaria Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20172
20181
20192
20206
20214
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8
Unknown status5
Completed4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Kartos Therapeutics, Inc.4
Karyopharm Therapeutics Inc2
Novartis Pharmaceuticals2
Sierra Oncology LLC - a GSK company2
Geron Corporation1
GlaxoSmithKline1
Swedish Orphan Biovitrum1
Takeda1
Telios Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis19
Neoplasms5
Anemia4
Myeloproliferative Disorders4
Bone Marrow Diseases2
Hematologic Diseases2
Polycythemia Vera2
Blood Platelet Disorders1
Bronchiolitis Obliterans Syndrome1
Graft vs Host Disease1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.